1. Home
  2. PGEN vs BNY Comparison

PGEN vs BNY Comparison

Compare PGEN & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • BNY
  • Stock Information
  • Founded
  • PGEN 1998
  • BNY 2001
  • Country
  • PGEN United States
  • BNY United States
  • Employees
  • PGEN N/A
  • BNY N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • BNY Trusts Except Educational Religious and Charitable
  • Sector
  • PGEN Health Care
  • BNY Finance
  • Exchange
  • PGEN Nasdaq
  • BNY Nasdaq
  • Market Cap
  • PGEN 475.2M
  • BNY 233.2M
  • IPO Year
  • PGEN N/A
  • BNY N/A
  • Fundamental
  • Price
  • PGEN $1.85
  • BNY $9.60
  • Analyst Decision
  • PGEN Strong Buy
  • BNY
  • Analyst Count
  • PGEN 3
  • BNY 0
  • Target Price
  • PGEN $6.00
  • BNY N/A
  • AVG Volume (30 Days)
  • PGEN 2.2M
  • BNY 52.7K
  • Earning Date
  • PGEN 08-13-2025
  • BNY 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • BNY 3.93%
  • EPS Growth
  • PGEN N/A
  • BNY N/A
  • EPS
  • PGEN N/A
  • BNY N/A
  • Revenue
  • PGEN $4,201,000.00
  • BNY N/A
  • Revenue This Year
  • PGEN $158.57
  • BNY N/A
  • Revenue Next Year
  • PGEN $1,086.91
  • BNY N/A
  • P/E Ratio
  • PGEN N/A
  • BNY N/A
  • Revenue Growth
  • PGEN N/A
  • BNY N/A
  • 52 Week Low
  • PGEN $0.65
  • BNY $8.60
  • 52 Week High
  • PGEN $2.17
  • BNY $10.80
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 68.77
  • BNY 43.10
  • Support Level
  • PGEN $1.56
  • BNY $9.59
  • Resistance Level
  • PGEN $2.04
  • BNY $9.71
  • Average True Range (ATR)
  • PGEN 0.11
  • BNY 0.07
  • MACD
  • PGEN 0.04
  • BNY 0.00
  • Stochastic Oscillator
  • PGEN 70.00
  • BNY 6.25

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About BNY BlackRock New York Municipal Income Trust

Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.

Share on Social Networks: